Genprex, Inc. (GNPX)
2.845
+0.44
(+18.54%)
USD |
NASDAQ |
Jan 14, 16:00
2.91
+0.06
(+2.28%)
After-Hours: 20:00
Genprex EPS Diluted (Quarterly): -4.996 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arvinas, Inc. | -0.4795 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.799M |
| Total Expenses (Quarterly) | 3.799M |
| Enterprise Value | 1.307M |
| Earnings Yield | -1.23K% |
| Normalized Earnings Yield | -1228.07 |